stockportfolio.pro
Stocks / AORT vs EYPT
AORT vs EYPT
Artivion, Inc. and EyePoint, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Artivion, Inc. (AORT) | EyePoint, Inc. (EYPT) | |
|---|---|---|
| Market cap | $1.0B | $1.0B |
| Revenue (latest FY) | $441.33M | $31.37M |
| Net income (latest FY) | $9.77M | $-231.96M |
| Revenue growth (5y CAGR) | 11.8% | -1.8% |
| Net margin | 2.2% | -739.4% |
| Return on equity | 2.2% | -75.8% |
| P/E ratio | 82.3 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 4 | 0 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open AORT — free Open EYPT — freeFrequently asked questions
Which is bigger, AORT or EYPT?
EyePoint, Inc. is larger by market capitalization — $1.0B versus $1.0B.
Which grows faster, AORT or EYPT?
Over the last five fiscal years, Artivion, Inc. grew revenue faster — 11.8%/yr versus -1.8%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.